Full Text
PMS43 Cost-Effectiveness of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in the Treatment of Severe Active RA

Abstract

Authors

J.J. Carlson S. Ogale F. Dejonckheere S.D. Sullivan

Back to Volume 15, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×